glp 1 with no gallbladder Can a GLP‑1 receptor agonist be prescribed to a diabetic patient who has had a cholecystectomy (no gallbladder)? GLP-1 After Gallbladder Removal: Safety
Description
Understanding what compounded versions are, how they compare to brand name drugs, and how to source them safely is critical for anyone navigating this transition
GLP-1RAs in obesity treatment Weight loss efficacy GLP-1 receptor agonists exhibit significant weight loss via many molecular routes
June 1, 2026: Over 100 Lawsuits in the GLP-1 NAION MDL, Ozempic Patient Sues After Becoming Blind from NAION The GLP-1 NAION multidistrict litigation now has 110 lawsuits in it, as of June 1, 2026
Studies indicate alarming discontinuation rates 53.6% of patients stop GLP-1 therapy within one year, and 72.2% discontinue within two years
doi: Schvarcz E, Palmer M, Aman J, Horowitz M, Stridsberg M, Berne C
Oral Market Dominance: despite the competition in injectables, Novo Nordisk retains a stronghold in the oral segment
